WEEKLY e-ALERT  [ BASIC EDITION ]
Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Expert Opinions
China's Removal of Imported Drug Tariffs: Implications for Foreign and Domestic Companies(6/21/2018 )  (Premium)
The Market
IQVia: Overview of Urban Chinese Hospital Drug Sales in 2017(6/20/2018 )  (Premium)
IQVia: Overview of Chinese Urban Retail Pharmacy Market in 2017(6/20/2018 )  (Premium)
Industry News
Tot Biopharm Opens New Biologics Facility in Suzhou(6/22/2018 )  (free)
Pacira Pharma and Nuance Biotech Announce License Agreement for EXPAREL in China(6/22/2018 )  (Premium)
CASI Pharma Enters Agreement With Yiling Wanzhou for Entecavir and Cilostazol(6/22/2018 )  (Premium)
Wuxi Biologics Initiated Construction of Integrated ADC Solution Center(6/20/2018 )  (Premium)
Cipla Reportedly in Talks with Desano for A Majority-owned Chinese JV(6/20/2018 )  (Premium)
Overview of Chinese In-licensing of Foreign Investigational New Drugs 2007-2017(6/20/2018 )  (Premium)
Pacira and Nuance Bio Announce License Agreement for Exparel in China(6/20/2018 )  (Premium)
Sedor and Los Altos Enter Greater China License Agreement for CE-Meloxicam(6/20/2018 )  (Premium)
Merck and Alibaba Health Announce Collaboration to Develop Patient-Centric Digital Services in China(6/19/2018 )  (Premium)
Johnson & Johnson Launches J&J Institute for Asia Pacific Region in Beijing(6/19/2018 )  (Premium)
Stealth Bio Announces $100M Financing to Advance Development of Elamipretide and Pipeline(6/19/2018 )  (Premium)
Alpha Biopharma Announces Series A Financing(6/19/2018 )  (free)
MNCs Lose Top Talents to Booming Domestic Biopharma Startups(6/19/2018 )  (Premium)
CITIC Capital Proposes To Acquire China Biologic for $3.65B(6/19/2018 )  (Premium)
India Releases Study for Enhancing Access to the Chinese Pharma Market(6/19/2018 )  (Premium)
Regulatory News
State Council Makes Decisions on Registration of Foreign New Drugs, Price Reduction of Anticancers and Shortage Drug Supply(6/21/2018 )  (Premium)
General Health
China's Antibiotic Consumption Lowered in 2017(6/20/2018 )  (Premium)
Legal/IPR News
MSF Challenges Gilead's Chinese Patent HCV Drug Velpatasvir(6/20/2018 )  (Premium)
Product/R&D News
Luye Pharma's Class 1.1 New Analgesic to Start Phase I Trial in China(6/20/2018 )  (Premium)
Other News
Upcoming Event: Shanghai eHealth Workshop(6/20/2018 )  (free)
European Chamber Warns China over Uneven Market Access and Treatment for EU Businesses(6/20/2018 )  (Premium)
© Wicon International GroupˇˇSupport by: www.heightow.com Home | Site map | Contact Us | Links